Low cholesterol levels are good markers for central hypothyroidism in case with dialysis using roxadustat

Key Clinical Message Recently, hypoxia‐inducible factor prolyl hydroxylase (HIF‐PH) inhibitors have been used for renal anemia, but side effects have also been reported. We report on the association of central hypothyroidism and cholesterol with roxadustat. Based on this case and previous reports, w...

Full description

Saved in:
Bibliographic Details
Published in:Clinical case reports 2024-09, Vol.12 (9), p.e9400
Main Authors: Kita, Serina, Okuyama, Hiroshi, Kondo, Takaya, Hayashi, Mizuki, Nakao, Shinichiro, Sawamura, Toshitaka, Fujimoto, Keiji, Nakagawa, Atsushi, Yokoyama, Hitoshi, Furuichi, Kengo
Format: Article
Language:English
Subjects:
Case Report
Nephrology
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Key Clinical Message Recently, hypoxia‐inducible factor prolyl hydroxylase (HIF‐PH) inhibitors have been used for renal anemia, but side effects have also been reported. We report on the association of central hypothyroidism and cholesterol with roxadustat. Based on this case and previous reports, we believe that patients receiving roxadustat should have their thyroid function and cholesterol levels checked regularly.
ISSN:2050-0904
2050-0904
DOI:10.1002/ccr3.9400